Featured review: Cancer stem cell metabolism
Even though cancer is now viewed as a stem cell disease, there is still no consensus on the metabolic characteristics of these cells. This review by Maria Peiris-Pagès et al.summarizes the latest findings and discoveries on cancer stem cell metabolism.
Articles
- RESEARCH ARTICLE
- RESEARCH ARTICLE
- RESEARCH ARTICLE
Intratumoral heterogeneity as a source of discordance in breast cancer biomarker classification
Published on: 28 June 2016 - RESEARCH ARTICLE
Clonal relationships between lobular carcinoma in situ and other breast malignancies
Published on: 23 June 2016 - RESEARCH ARTICLE
Mammographic density and risk of breast cancer by mode of detection and tumor size: a case-control study
Published on: 18 June 2016
Meet the Editor-in-Chief
Dr. Lewis A. Chodosh is a physician-scientist who received a BS in Molecular Biophysics and Biochemistry from Yale University, and MD from Harvard Medical School, and a PhD. in Biochemistry from M.I.T. in the laboratory of Dr. Phillip Sharp. He performed his clinical training in Internal Medicine and Endocrinology at the Massachusetts General Hospital, after which he was a postdoctoral research fellow with Dr. Philip Leder at Harvard Medical School. Dr. Chodosh joined the faculty of the University of Pennsylvania in 1994, where he is currently a Professor in the Departments of Cancer Biology, Cell & Developmental Biology, and Medicine. He serves as Chairman of the Department of Cancer Biology, Associate Director for Basic Science of the Abramson Cancer Center, and Director of Cancer Genetics for the Abramson Family Cancer Research Institute at the University of Pennsylvania. Additionally, he is on the scientific advisory board for the Harvard Nurses' Health Studies I and II.
Dr. Chodosh's research focuses on genetic, genomic and molecular approaches to understanding breast cancer susceptibility and pathogenesis.
FEATURED THEMATIC SERIES - Lobular Breast Cancer
This special series takes a translational view of lobular breast cancer, from bedside to bench and back. The second most common breast cancer subtype, lobular breast cancer displays many unique molecular and clinical properties. Leaders in the field explore the molecular biology, pathology, risk factors, imaging, treatment and prognosis of this breast cancer.
For further information or enquiries please contact Customer Services at:info@biomedcentral.com.
BioMed Central Ltd
236 Gray's Inn Road, London, WC1X 8HB,
United Kingdom.
No hay comentarios:
Publicar un comentario